Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

Abstract Background This study aimed to evaluate the feasibility, safety, and efficacy of postoperative adjuvant chemotherapy with docetaxel/cisplatin/S-1 (DCS) following S-1 therapy in patients with stage III gastric cancer after curative gastrectomy. Methods Patients with stage III gastric cancer...

Full description

Bibliographic Details
Main Authors: Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Tetsu Yamamoto, Ryoji Hyakudomi, Kiyoe Takai, Kazunari Ishitobi, Yuki Uchida, Yoshitsugu Tajima
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
Docetaxel/cisplatin/S-1
Gastric cancer
Adjuvant chemotherapy
R0 resection
Online Access:https://doi.org/10.1186/s12885-021-08795-4

Internet

https://doi.org/10.1186/s12885-021-08795-4

Similar Items